Irish pharma still risks wildcard Section 232 tariffs, despite Trump’s trade agreement

euractiv.com/section/health-consumers/news/irish-pharma-still-risks-wildcard-section-232-tariffs-despite-trumps-trade-agreement

Muted enthusiasm for this week’s US-EU trade agreement did little to dispel concerns that the US has unfinished business with Ireland’s pharmaceutical sector.

This story appeared on euractiv.com, 2025-07-31 12:02:50.
The Entire Business World on a Single Page. Free to Use →